Biosecurity as Governance: What Ethnically Targeted Weapons Reveal About Institutional Failure
There is a category of risk that institutional frameworks consistently underweight: threats that operate at the intersection of cutting-edge science, ethnic and genomic targeting, and geopolitical incentive. Ethnically targeted biological weapons sit at that intersection.
The concept is not new. The idea that a pathogen might be engineered to exploit genetic markers associated with specific population groups has been discussed in biosecurity literature for decades. What has changed is the convergence of technologies that makes the question more urgent: lower-cost gene sequencing, expanding genomic databases stratified by ancestry, and the democratization of synthetic biology tools.
The Governance Gap
Most international arms control frameworks were designed for a different era of weapons technology. The Biological Weapons Convention (BWC) of 1972 prohibits the development and stockpiling of biological weapons but lacks a formal verification mechanism, a known structural weakness. More critically, it was designed before the genomic revolution made population-level targeting a theoretical possibility.
The governance gap is not just a technical oversight. It reflects a broader pattern in institutional design: regulations tend to address the threats of the last era rather than anticipating the next one. Biosecurity governance has not kept pace with the synthetic biology revolution.
Why This Is a Social Science Problem as Much as a Biological One
Engineering a pathogen is a scientific challenge. Deciding whether to use one (and organizing a state or non-state actor to do so) is a social, political, and institutional question. The incentive structures, oversight mechanisms, and normative constraints that make such a decision more or less likely are exactly where social science analysis is most valuable.
From a governance perspective, the real question is not just whether a threat is technically possible but whether institutional frameworks are designed to detect, deter, and respond to it. Currently, the answer is unsatisfying. Biosecurity monitoring is fragmented, international verification is weak, and the political incentive to treat this as a priority tends to emerge only after incidents force the issue.
What Stronger Institutional Design Would Look Like
Effective biosecurity governance would need to address three levels: technical monitoring (surveillance of dual-use research), institutional accountability (verification mechanisms with real teeth), and normative reinforcement (making targeted biological development costly in reputational and diplomatic terms).
None of this is novel insight. Biosecurity experts have argued for strengthened verification and monitoring for years. What’s notable is how slowly the institutional response moves relative to the pace of the underlying technology.
This post explores the institutional design questions around biosecurity, a topic that sits at the intersection of governance, science policy, and international relations that I’m interested in as an incoming HSPS student at Cambridge.